<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:ali="http://www.niso.org/schemas/ali/1.0" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Genomics Inform</journal-id>
      <journal-id journal-id-type="iso-abbrev">Genomics Inform</journal-id>
      <journal-id journal-id-type="publisher-id">GNI</journal-id>
      <journal-title-group>
        <journal-title>Genomics &amp; Informatics</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">1598-866X</issn>
      <issn pub-type="epub">2234-0742</issn>
      <publisher>
        <publisher-name>Korea Genome Organization</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">26175662</article-id>
      <article-id pub-id-type="pmc">4500798</article-id>
      <article-id pub-id-type="doi">10.5808/GI.2015.13.2.45</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Original Article</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Elucidation of the Molecular Interaction between miRNAs and the <italic>HOXA9</italic> Gene, Involved in Acute Myeloid Leukemia, by the Assistance of Argonaute Protein through a Computational Approach</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Das</surname>
            <given-names>Rohit Pritam</given-names>
          </name>
          <xref ref-type="aff" rid="A1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Konkimalla</surname>
            <given-names>V. Badireenath</given-names>
          </name>
          <xref ref-type="aff" rid="A2">2</xref>
        </contrib>
        <contrib contrib-type="author" corresp="yes">
          <name>
            <surname>Rath</surname>
            <given-names>Surya Narayan</given-names>
          </name>
          <xref ref-type="aff" rid="A1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Hansa</surname>
            <given-names>Jagadish</given-names>
          </name>
          <xref ref-type="aff" rid="A3">3</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Jagdeb</surname>
            <given-names>Manaswini</given-names>
          </name>
          <xref ref-type="aff" rid="A1">1</xref>
        </contrib>
      </contrib-group>
      <aff id="A1"><label>1</label>BIF Centre, Department of Bioinformatics, Orissa University of Agriculture &amp; Technology, Bhubaneswar 751003, India.</aff>
      <aff id="A2"><label>2</label>School of Biological Sciences, National Institute of Science Education and Research, Bhubaneswar 751005, India.</aff>
      <aff id="A3"><label>3</label>Department of Surgical Oncology, IMS and SUM Hospital, SOA University, Bhubaneswar 751003, India.</aff>
      <author-notes>
        <corresp>Corresponding author: Tel: +91-06742-565760, Fax: +91-06742-565760, <email>snrbioinfo@gmail.com</email></corresp>
      </author-notes>
      <pub-date pub-type="ppub">
        <month>6</month>
        <year>2015</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>30</day>
        <month>6</month>
        <year>2015</year>
      </pub-date>
      <volume>13</volume>
      <issue>2</issue>
      <fpage>45</fpage>
      <lpage>52</lpage>
      <history>
        <date date-type="received">
          <day>03</day>
          <month>3</month>
          <year>2015</year>
        </date>
        <date date-type="rev-recd">
          <day>29</day>
          <month>3</month>
          <year>2015</year>
        </date>
        <date date-type="accepted">
          <day>31</day>
          <month>3</month>
          <year>2015</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>Copyright &#xA9; 2015 by the Korea Genome Organization</copyright-statement>
        <copyright-year>2015</copyright-year>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/3.0/">
          <license-p>It is identical to the Creative Commons Attribution Non-Commercial License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc/3.0/">http://creativecommons.org/licenses/by-nc/3.0/</ext-link>).</license-p>
        </license>
      </permissions>
      <abstract>
        <p>Acute myeloid leukemia is a well characterized blood cancer in which the unnatural growth of immature white blood cell takes place, where several genes transcription is regulated by the micro RNAs (miRNAs). Argonaute (AGO) protein is a protein family that binds to the miRNAs and mRNA complex where a strong binding affinity is crucial for its RNA silencing function. By understanding pattern recognition between the miRNAs-mRNA complex and its binding affinity with AGO protein, one can decipher the regulation of a particular gene and develop suitable siRNA for the same in disease condition. In the current work, <italic>HOXA9</italic> gene has been selected from literature, whose deregulation is well-established in acute myeloid leukemia. Four miRNAs (mir-145, mir-126, let-7a, and mir-196b) have been selected to target mRNA of <italic>HOXA9</italic> (NCBI accession No. NM_152739.3). The binding interaction between mRNAs and mRNA of <italic>HOXA9</italic> gene was studied computationally. From result, it was observed mir-145 has highest affinity for <italic>HOXA9</italic> gene. Furthermore, the interaction between miRNAs-mRNA duplex of all chosen miRNAs are docked with AGO protein (PDB ID: 3F73, chain A) to study their interaction at molecular level through an <italic>in silico</italic> approach. The residual interaction and hydrogen bonding are inspected in Discovery Studio 3.5 suites. The current investigation throws light on understanding of AGO-assisted miRNA based gene silencing mechanism in <italic>HOXA9</italic> gene associated in acute myeloid leukemia computationally.</p>
      </abstract>
      <kwd-group>
        <kwd>acute myeloid leukemia</kwd>
        <kwd>Argonaute</kwd>
        <kwd>
          <italic>HOXA9</italic>
        </kwd>
        <kwd>
          <italic>in silico</italic>
        </kwd>
        <kwd>microRNAs</kwd>
        <kwd>mRNA</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec sec-type="intro">
      <title>Introduction</title>
      <p>MicroRNAs (miRNAs) are small non-coding single stranded RNAs (~18-22 bp) found in most eukaryotes, playing a crucial role in a wide range of biological processes, such as host-viral interaction, apoptosis, stem cell maintenance, and metabolism, etc. miRNAs are involved in gene silencing mechanisms by targeting un-translated regions of mRNA through sequence complementarity [<xref rid="B1" ref-type="bibr">1</xref><xref rid="B2" ref-type="bibr">2</xref>], and approximately 30% of protein-coding genes are regulated by miRNAs [<xref rid="B3" ref-type="bibr">3</xref>]. As many genes can be regulated by a single or multiple miRNAs, an immense interest has been created to understand miRNA-based gene regulation through the identification of miRNAs, as well as their target genes. The Argonaute (AGO) class of proteins plays a crucial functional role in the molecular recognition of miRNA-mRNA hybrids during the process of gene regulation [<xref rid="B4" ref-type="bibr">4</xref><xref rid="B5" ref-type="bibr">5</xref>], and mutations in either the sequence of miRNAs or the miRNA target sites have a significant contribution in the manifestation of cancer due to the loss of gene regulation [<xref rid="B5" ref-type="bibr">5</xref><xref rid="B6" ref-type="bibr">6</xref>].</p>
      <p>Leukemia is a cancer of white blood cells that is commonly classified as acute myeloid leukemia (AML), acute lymphoblastic leukemia, and chronic lymphoblastic leukemia. AML is a well-characterized blood cancer in which the unnatural growth of immature white blood cells takes place, where several genes involved are either up-regulated or down regulated by miRNAs. Though the importance of miRNAs in gene regulation [<xref rid="B2" ref-type="bibr">2</xref><xref rid="B3" ref-type="bibr">3</xref><xref rid="B4" ref-type="bibr">4</xref><xref rid="B5" ref-type="bibr">5</xref><xref rid="B7" ref-type="bibr">7</xref><xref rid="B8" ref-type="bibr">8</xref>] and their regulation by RNA-induced silencing complexes [<xref rid="B7" ref-type="bibr">7</xref>] are well established, the mechanism of miRNA-induced gene silencing at the molecular level is still unclear [<xref rid="B9" ref-type="bibr">9</xref><xref rid="B10" ref-type="bibr">10</xref>]. Despite several detailed research studies, controlling abnormal cell proliferation at the molecular level through miRNA-mediated gene silencing is still a major challenge. Therefore, with the current knowledge, attempts have been made to study the AGO protein-assisted molecular interaction between miRNAs and their target genes, and a computational approach [<xref rid="B11" ref-type="bibr">11</xref>] in this regard will be of great aid and value. Here, in this study, the <italic>HOXA9</italic> gene was selected from the literature as an important target in AML, and <italic>in silico</italic> approaches, like miRNA target site prediction, miRNA-mRNA duplex prediction, and molecular docking between AGO protein and four miRNAs, such as mir-145, mir-126, let7a, and mir-196b [<xref rid="B8" ref-type="bibr">8</xref><xref rid="B12" ref-type="bibr">12</xref><xref rid="B13" ref-type="bibr">13</xref>], were conducted to elucidate the AGO protein-assisted molecular interaction between miRNAs and the <italic>HOXA9</italic> gene in association with AML [<xref rid="B14" ref-type="bibr">14</xref><xref rid="B15" ref-type="bibr">15</xref>] computationally.</p>
    </sec>
    <sec sec-type="methods">
      <title>Methods</title>
      <sec>
        <title>Selection of <italic>HOXA9</italic> gene as a target in AML</title>
        <p>The leukemia gene database (<ext-link ext-link-type="uri" xlink:href="http://www.bioinformatics.org/legend/leuk_db.htm">http://www.bioinformatics.org/legend/leuk_db.htm</ext-link>) documented the <italic>AF10</italic>, <italic>NUP98</italic>, <italic>CBFB</italic>, <italic>NUP214</italic>, <italic>HOXA9</italic>, <italic>CREBBP</italic>, <italic>ARHGEF12</italic>, <italic>CDX2</italic>, <italic>LCP1</italic>, <italic>CEBPA</italic>, <italic>DEK</italic>, <italic>FUS</italic>, and <italic>RUNX1</italic> genes to be involved in AML. Among them, the <italic>HOXA9</italic> gene is reported to have major relevance to their regulatory functions and aberrant expression in both mice and humans [<xref rid="B14" ref-type="bibr">14</xref><xref rid="B15" ref-type="bibr">15</xref>]. Furthermore, identification of miRNAs that target the <italic>HOXA9</italic> gene would help us to understand its interaction at the molecular level in AML conditions.</p>
      </sec>
      <sec>
        <title>Selection of miRNAs targeting the <italic>HOXA9</italic> gene</title>
        <p>Firstly, from the literature, the miRNAs with affinity for the <italic>HOXA9</italic> gene were identified [<xref rid="B12" ref-type="bibr">12</xref><xref rid="B13" ref-type="bibr">13</xref>], which was further verified by prediction of miRNA target sites in the <italic>HOXA9</italic> gene using the miRTarBase web server (<ext-link ext-link-type="uri" xlink:href="http://mirtarbase.mbc.nctu.edu.tw/">http://mirtarbase.mbc.nctu.edu.tw/</ext-link>). The search showed four miRNAs-namely, mir-145, mir-126, let-7a, and mir-196b-that have target sites within <italic>HOXA9</italic> (<xref ref-type="supplementary-material" rid="S1">Supplementary Tables 1</xref> and <xref ref-type="supplementary-material" rid="S2">2</xref>). Two different binding sites were identified for mir-196b in the <italic>HOXA9</italic> gene, denoted mir-196b.1 and mir-196b.2, respectively.</p>
      </sec>
      <sec>
        <title>Prediction of duplex between miRNAs and mRNA of the <italic>HOXA9</italic> gene</title>
        <p>A computational approach was carried out to study the binding mode of selected miRNAs (mir-145, mir-126, let-7a, mir-196b.1, and mir-196b.2) with the mRNA of <italic>HOXA9</italic> to confirm the selection of the best miRNA. The properties, like predicted binding sites of <italic>HOXA9</italic> for miRNAs (<xref ref-type="supplementary-material" rid="S3">Supplementary Table 3</xref>) and minimum free energy (MFE) score of duplex interactions, were used for confirmation of binding. Two different duplexes were formed for mir-196b (represented as mir-196b.1 and mir-196b.2) with <italic>HOXA9</italic> due to the identification of two target sites in <italic>HOXA9</italic> (<xref ref-type="supplementary-material" rid="S3">Supplementary Table 3</xref>). The MFE scores for folding of miRNAs and the mRNA duplex (<xref ref-type="supplementary-material" rid="S4">Supplementary Table 4</xref>) were calculated using the mfold web server (<ext-link ext-link-type="uri" xlink:href="http://mfold.rna.albany.edu/?q=mfold">http://mfold.rna.albany.edu/?q=mfold</ext-link>). The appropriate secondary structures of miRNAs and the mRNA duplex (<xref ref-type="supplementary-material" rid="S4">Supplementary Table 4</xref>) were predicted using the Centroid Fold web server (<ext-link ext-link-type="uri" xlink:href="http://www.ncrna.org/centroidfold/">http://www.ncrna.org/centroidfold/</ext-link>). The prediction of tertiary structures of the duplex were performed in 3dRNA web server (<ext-link ext-link-type="uri" xlink:href="http://biophy.hust.edu.cn/3dRNA/3dRNA.html">http://biophy. hust.edu.cn/3dRNA/3dRNA.html</ext-link>) using dot bracket structures (<xref ref-type="supplementary-material" rid="S4">Supplementary Table 4</xref>) that resulted from the Centroid Fold.</p>
      </sec>
      <sec>
        <title>Molecular interaction between miRNAs and AGO protein</title>
        <p>To illustrate the assistance of catalytic AGO protein for the binding of miRNAs (mir-145, mir-126, let-7a, mir-196b.1, and mir-196b.2) with the <italic>HOXA9</italic> gene, docking between AGO protein and miRNA-mRNA duplexes was performed in the PachDock online server [<xref rid="B16" ref-type="bibr">16</xref>]. The PachDock algorithm ranked the docked complexes on the basis of geometrical shape complementary scores. Close amino acid residue interactions and participating atoms in hydrogen bonding were inspected and analyzed in the Discovery Studio 3.5 suite (<ext-link ext-link-type="uri" xlink:href="http://accelrys.com/products/discovery-studio/visualization-download.php">http://accelrys.com/products/discovery-studio/visualization-download.php</ext-link>).</p>
      </sec>
    </sec>
    <sec sec-type="results">
      <title>Results</title>
      <sec>
        <title>Duplex interaction between miRNAs and mRNA of the <italic>HOXA9</italic> gene</title>
        <p>The leukemia gene database search result, supported by literature evidence [<xref rid="B14" ref-type="bibr">14</xref><xref rid="B15" ref-type="bibr">15</xref>], signifies that <italic>HOXA9</italic> (NCBI accession No. NM_152739.3) has aberrant expression at the molecular level and was therefore selected as a target gene in AML. Four miRNAs-namely, mir-145, mir-126, let-7a, and mir-196b (<xref ref-type="supplementary-material" rid="S2">Supplementary Table 2</xref>)-were taken from the literature, and their target sites in the <italic>HOXA9</italic> gene were verified through the miRTarBase web server. The predicted binding regions in the <italic>HOXA9</italic> gene (<xref ref-type="supplementary-material" rid="S1">Supplementary Tables 1</xref> and <xref ref-type="supplementary-material" rid="S3">3</xref>) for the miRNAs above were supported by good MFE scores calculated for the miRNAs and mRNA duplex (<xref ref-type="supplementary-material" rid="S4">Supplementary Table 4</xref>) using the mfold web server, which implicates a strong affinity between them at the molecular level. Three-dimensional binding modes of all miRNAs and mRNA duplexes (mir-145, mir-126, let-7a, mir-196b.1, and mir-196b.2) were constructed and deciphered (<xref ref-type="fig" rid="F1">Fig. 1A-1E</xref>) using the Discovery Studio 3.5 suite.</p>
      </sec>
      <sec>
        <title>Study of binding affinity between miRNAs and AGO protein through docking</title>
        <p>The three-dimensional structure of AGO protein, with 685 amino acid residues, was retrieved from Protein Data Bank (PDB ID: 3F73, chain A). The AGO protein is a silencing complex structure with a seed containing guide DNA and target RNA duplexes. The structure preparation and correction of AGO protein were performed in Discovery Studio 3.5 suite before docking. The docking between miRNA-mRNA duplexes (mir-145, mir-126, let-7a, mir-196b.1, and mir-196b.2) and AGO protein was carried out separately in the PachDock online server on the basis of geometrical shape complementary scores. Out of 10 binding complexes generated for each miRNA-mRNA duplex docked with AGO protein, the highest-scoring complex was chosen as the best binding mode. However, a good dock score in all cases of docking between the selected miRNAs (mir-145, mir-126, let-7a, and mir-196b) and AGO protein implicated a strong interaction between them at the molecular level (<xref ref-type="supplementary-material" rid="S5">Supplementary Table 5</xref>).</p>
      </sec>
      <sec>
        <title>Study of interaction between miRNAs and AGO protein at the molecular level</title>
        <p>Strong hydrophobic amino acid residues and amino acids with aromatic rings, which are relatively hydrophobic in nature, generally take part in hydrophobic interactions and contribute towards the stability in binding moieties while the protein interacts with macromolecules. From the inspection of the close amino acid residues of AGO protein surrounding the miRNAs (mir-145, mir-126, let-7a, mir-196b.1, and mir-196b.2), some strongly hydrophobic amino acids, like LEU 652, LEU 267, ALA 644, and ALA 648 in mir-145; LEU 267, LEU 277, LEU 279, LEU 281, ALA 278, ALA 648, and VAL 606 in mir-126; LEU 267, LEU 279, LEU 281, and ALA 278in let-7a; ALA 111, VAL 58, and LEU 132 in mir-196b.1; and VAL 549, VAL 152, and ALA 170 in mir-196b.2, were observed within a distance of 3.5 &#xC5; (<xref ref-type="table" rid="T1">Table 1</xref>, <xref ref-type="fig" rid="F2">Fig. 2A-2E</xref>). Similarly, amino acids, like TYR 642, PHE 649, and PHE 647 in mir-145; PHE 649 in mir-126; and TYR 171 and TYR 135 in mir-196b.2, with aromatic rings were also found in the binding pocket of miRNAs (<xref ref-type="table" rid="T1">Table 1</xref>, <xref ref-type="fig" rid="F2">Fig. 2A-2E</xref>) within a distance of 3.5 &#xC5;. The study of hydrogen bonding patterns between atoms is another major parameter to study the stability of interactions between bio-molecules at their atomic level. Some amino acids, like ARG 615, ARG 651, HIS 445, and PHE 649 in mir-145; SER 280, HIS 607, and THR 613 in mir-126; SER 280, ARG 608, GLY 612, LEU 281, and THR 613 in let-7a; ARG 51 and ARG 59 in mir-196b.1; and SER 576, GLY 577, ARG 580, and ARG 615 in mir-196b.2 (<xref ref-type="table" rid="T1">Tables 1</xref> and <xref ref-type="table" rid="T2">2</xref>, <xref ref-type="fig" rid="F3">Fig. 3A-3E</xref>), were observed to participate in hydrogen bonding with miRNAs within the binding pocket.</p>
      </sec>
    </sec>
    <sec sec-type="discussion">
      <title>Discussion</title>
      <p>The current study focused on <italic>in silico</italic> verification of miRNAs for targeting the <italic>HOXA9</italic> gene, associated in AML, and the molecular interaction of catalytic AGO protein with these miRNAs to study the gene silencing mechanism computationally. As the literature has reported [<xref rid="B12" ref-type="bibr">12</xref><xref rid="B13" ref-type="bibr">13</xref>], four mature miRNAs-namely, miR-145, mir-126, let-7a, and mir-196b-are found to have target sites in the <italic>HOXA9</italic> gene and were hence taken for further study. The binding sites in <italic>HOXA9</italic> were predicted for these miRNAs using miRTarBase (<xref ref-type="supplementary-material" rid="S1">Supplementary Tables 1</xref> and <xref ref-type="supplementary-material" rid="S3">3</xref>), which was followed by the secondary structure prediction and miRNA-mRNA duplex formation. Two binding sites were predicted for mir-196b in the <italic>HOXA9</italic> gene (<xref ref-type="supplementary-material" rid="S1">Supplementary Table 1</xref>), denoted mir-196b.1 and mir-196b.2, respectively; so, two duplexes are formed between mir-196b and mRNA of the <italic>HOXA9</italic> gene (<xref ref-type="supplementary-material" rid="S3">Supplementary Table 3</xref>). The results suggested a strong and energetically favorable binding mode between all miRNA-mRNA duplexes (<xref ref-type="supplementary-material" rid="S4">Supplementary Table 4</xref>), which is also supported by the reported interaction between them (<xref ref-type="fig" rid="F1">Fig. 1</xref>). The good MFE score (-5.90 kcal/mol) also reflected that mir-145 had the highest binding affinity for the <italic>HOXA9</italic> gene (<xref ref-type="supplementary-material" rid="S4">Supplementary Table 4</xref>) among all miRNAs. Furthermore, to study the molecular interaction between AGO protein and miRNA-mRNA duplexes (miR-145, mir-126, let-7a, mir-196b.1, and mir-196b.2), molecular docking was carried out. The presence of strong hydrophobic amino acid residues (LEU 652, LEU 267, ALA 644, and ALA 648 in mir-145; LEU 267, LEU 277, LEU 279, LEU 281, ALA 278, ALA 648, and VAL 606 in mir-126; LEU 267, LEU 279, LEU 281, and ALA 278 in let-7a; ALA 111, VAL 58, and LEU 132 in mir-196b.1; and VAL 549, VAL 152, and ALA 170 in mir-196b.2) within a distance of 3.5 &#xC5; in the binding pocket of miRNAs implicates strong binding interactions at the molecular level between AGO protein and all chosen miRNAs (<xref ref-type="table" rid="T1">Table 1</xref>, <xref ref-type="fig" rid="F2">Fig. 2A-2E</xref>). Also, amino acids with aromatic rings (TYR 642, PHE 649, and PHE 647 in mir-145; PHE 649 in mir-126; and TYR 171 and TYR 135 in mir-196b.2) were also observed within a distance of 3.5 &#xC5;, which supports the binding interaction (<xref ref-type="table" rid="T1">Table 1</xref>, <xref ref-type="fig" rid="F2">Fig. 2A-2E</xref>) between AGO protein and miRNAs. The amino acid residues participated in hydrogen bonding (<xref ref-type="table" rid="T2">Table 2</xref>, <xref ref-type="fig" rid="F3">Fig. 3A-3E</xref>) with miRNAs (miR-145, mir-126, let-7a, mir-196b.1, and mir-196b.2) within a distance of 3.0 &#xC5;, showing strong evidence of binding and a molecular interaction between AGO protein and all chosen miRNAs. The current investigation proved that mir-145, mir-126, let-7a, mir-196b.1, and mir-196b.2 have strong binding affinity for the <italic>HOXA9</italic> gene and also throws light on AGO protein-assisted molecular interactions with miRNA-mRNA duplex structures. This report would be helpful in understanding miRNA-based gene silencing mechanisms for the <italic>HOXA9</italic> gene in AML disease. Furthermore, a molecular dynamic simulation approach might be implemented to study the dynamic behavior of these interactions, which would help us better understand miRNA-based gene silencing mechanisms in AML computationally. Once validated experimentally, this methodology would further help us to design suitable miRNAs against respective genes rationally.</p>
    </sec>
  </body>
  <back>
    <ack>
      <title>Acknowledgments</title>
      <p>The authors are thankful to the Department of Biotechnology, Govt. of India, for providing the BIF Centre facility to carry out the current research work. Also, the authors are grateful to the authorities of the Department of Bioinformatics, Centre for Post Graduate Studies, Orissa University of Agriculture &amp; Technology, Bhubaneswar, Odisha, India, for their constant encouragement and allowing this research work to be accomplished.</p>
    </ack>
    <ref-list>
      <ref id="B1">
        <label>1</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Didiano</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Hobert</surname>
              <given-names>O</given-names>
            </name>
          </person-group>
          <article-title>Molecular architecture of a miRNA-regulated 3' UTR</article-title>
          <source>RNA</source>
          <year>2008</year>
          <volume>14</volume>
          <fpage>1297</fpage>
          <lpage>1317</lpage>
          <pub-id pub-id-type="pmid">18463285</pub-id>
        </element-citation>
      </ref>
      <ref id="B2">
        <label>2</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gu</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Xu</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Xie</surname>
              <given-names>X</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Ko</surname>
              <given-names>JH</given-names>
            </name>
            <name>
              <surname>Zhou</surname>
              <given-names>T</given-names>
            </name>
          </person-group>
          <article-title>The role of RNA structure at 5' untranslated region in microRNA-mediated gene regulation</article-title>
          <source>RNA</source>
          <year>2014</year>
          <volume>20</volume>
          <fpage>1369</fpage>
          <lpage>1375</lpage>
          <pub-id pub-id-type="pmid">25002673</pub-id>
        </element-citation>
      </ref>
      <ref id="B3">
        <label>3</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rajewsky</surname>
              <given-names>N</given-names>
            </name>
          </person-group>
          <article-title>MicroRNA target predictions in animals</article-title>
          <source>Nat Genet</source>
          <year>2006</year>
          <volume>38</volume>
          <issue>Suppl</issue>
          <fpage>S8</fpage>
          <lpage>S13</lpage>
          <pub-id pub-id-type="pmid">16736023</pub-id>
        </element-citation>
      </ref>
      <ref id="B4">
        <label>4</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hutvagner</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Simard</surname>
              <given-names>MJ</given-names>
            </name>
          </person-group>
          <article-title>Argonaute proteins: key players in RNA silencing</article-title>
          <source>Nat Rev Mol Cell Biol</source>
          <year>2008</year>
          <volume>9</volume>
          <fpage>22</fpage>
          <lpage>32</lpage>
          <pub-id pub-id-type="pmid">18073770</pub-id>
        </element-citation>
      </ref>
      <ref id="B5">
        <label>5</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Farazi</surname>
              <given-names>TA</given-names>
            </name>
            <name>
              <surname>Ten Hoeve</surname>
              <given-names>JJ</given-names>
            </name>
            <name>
              <surname>Brown</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Mihailovic</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Horlings</surname>
              <given-names>HM</given-names>
            </name>
            <name>
              <surname>van de Vijver</surname>
              <given-names>MJ</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Identification of distinct miRNA target regulation between breast cancer molecular subtypes using AGO2-PAR-CLIP and patient datasets</article-title>
          <source>Genome Biol</source>
          <year>2014</year>
          <volume>15</volume>
          <fpage>R9</fpage>
          <pub-id pub-id-type="pmid">24398324</pub-id>
        </element-citation>
      </ref>
      <ref id="B6">
        <label>6</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Betel</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Koppal</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Agius</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Sander</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Leslie</surname>
              <given-names>C</given-names>
            </name>
          </person-group>
          <article-title>Comprehensive modeling of microRNA targets predicts functional non-conserved and non-canonical sites</article-title>
          <source>Genome Biol</source>
          <year>2010</year>
          <volume>11</volume>
          <fpage>R90</fpage>
          <pub-id pub-id-type="pmid">20799968</pub-id>
        </element-citation>
      </ref>
      <ref id="B7">
        <label>7</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Macfarlane</surname>
              <given-names>LA</given-names>
            </name>
            <name>
              <surname>Murphy</surname>
              <given-names>PR</given-names>
            </name>
          </person-group>
          <article-title>MicroRNA: biogenesis, function and role in cancer</article-title>
          <source>Curr Genomics</source>
          <year>2010</year>
          <volume>11</volume>
          <fpage>537</fpage>
          <lpage>561</lpage>
          <pub-id pub-id-type="pmid">21532838</pub-id>
        </element-citation>
      </ref>
      <ref id="B8">
        <label>8</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Reinhart</surname>
              <given-names>BJ</given-names>
            </name>
            <name>
              <surname>Slack</surname>
              <given-names>FJ</given-names>
            </name>
            <name>
              <surname>Basson</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Pasquinelli</surname>
              <given-names>AE</given-names>
            </name>
            <name>
              <surname>Bettinger</surname>
              <given-names>JC</given-names>
            </name>
            <name>
              <surname>Rougvie</surname>
              <given-names>AE</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>The 21-nucleotide let-7 RNA regulates developmental timing in <italic>Caenorhabditis elegans</italic></article-title>
          <source>Nature</source>
          <year>2000</year>
          <volume>403</volume>
          <fpage>901</fpage>
          <lpage>906</lpage>
          <pub-id pub-id-type="pmid">10706289</pub-id>
        </element-citation>
      </ref>
      <ref id="B9">
        <label>9</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Eulalio</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Huntzinger</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Izaurralde</surname>
              <given-names>E</given-names>
            </name>
          </person-group>
          <article-title>Getting to the root of miRNA-mediated gene silencing</article-title>
          <source>Cell</source>
          <year>2008</year>
          <volume>132</volume>
          <fpage>9</fpage>
          <lpage>14</lpage>
          <pub-id pub-id-type="pmid">18191211</pub-id>
        </element-citation>
      </ref>
      <ref id="B10">
        <label>10</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ahmad</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Hasnain</surname>
              <given-names>SE</given-names>
            </name>
            <name>
              <surname>Siddiqui</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>Ahamed</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Musarrat</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Al-Khedhairy</surname>
              <given-names>AA</given-names>
            </name>
          </person-group>
          <article-title>MicroRNA in carcinogenesis and cancer diagnostics: a new paradigm</article-title>
          <source>Indian J Med Res</source>
          <year>2013</year>
          <volume>137</volume>
          <fpage>680</fpage>
          <lpage>694</lpage>
          <pub-id pub-id-type="pmid">23703335</pub-id>
        </element-citation>
      </ref>
      <ref id="B11">
        <label>11</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wang</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Ma</surname>
              <given-names>Z</given-names>
            </name>
            <name>
              <surname>Yang</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Ai</surname>
              <given-names>C</given-names>
            </name>
          </person-group>
          <article-title>Mechanism of microRNA-target interaction: molecular dynamics simulations and thermodynamics analysis</article-title>
          <source>PLoS Comput Biol</source>
          <year>2010</year>
          <volume>6</volume>
          <fpage>e1000866</fpage>
          <pub-id pub-id-type="pmid">20686687</pub-id>
        </element-citation>
      </ref>
      <ref id="B12">
        <label>12</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Shen</surname>
              <given-names>WF</given-names>
            </name>
            <name>
              <surname>Hu</surname>
              <given-names>YL</given-names>
            </name>
            <name>
              <surname>Uttarwar</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Passegue</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Largman</surname>
              <given-names>C</given-names>
            </name>
          </person-group>
          <article-title>MicroRNA-126 regulates HOXA9 by binding to the homeobox</article-title>
          <source>Mol Cell Biol</source>
          <year>2008</year>
          <volume>28</volume>
          <fpage>4609</fpage>
          <lpage>4619</lpage>
          <pub-id pub-id-type="pmid">18474618</pub-id>
        </element-citation>
      </ref>
      <ref id="B13">
        <label>13</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Li</surname>
              <given-names>Z</given-names>
            </name>
            <name>
              <surname>Huang</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Chen</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>He</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Arnovitz</surname>
              <given-names>S</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>miR-196b directly targets both <italic>HOXA9/MEIS1</italic> oncogenes and FAS tumour suppressor in MLL-rearranged leukaemia</article-title>
          <source>Nat Commun</source>
          <year>2012</year>
          <volume>3</volume>
          <fpage>688</fpage>
          <pub-id pub-id-type="pmid">22353710</pub-id>
        </element-citation>
      </ref>
      <ref id="B14">
        <label>14</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Thorsteinsdottir</surname>
              <given-names>U</given-names>
            </name>
            <name>
              <surname>Kroon</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Jerome</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Blasi</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Sauvageau</surname>
              <given-names>G</given-names>
            </name>
          </person-group>
          <article-title>Defining roles for <italic>HOX</italic> and <italic>MEIS1</italic> genes in induction of acute myeloid leukemia</article-title>
          <source>Mol Cell Biol</source>
          <year>2001</year>
          <volume>21</volume>
          <fpage>224</fpage>
          <lpage>234</lpage>
          <pub-id pub-id-type="pmid">11113197</pub-id>
        </element-citation>
      </ref>
      <ref id="B15">
        <label>15</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Alharbi</surname>
              <given-names>RA</given-names>
            </name>
            <name>
              <surname>Pettengell</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Pandha</surname>
              <given-names>HS</given-names>
            </name>
            <name>
              <surname>Morgan</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <article-title>The role of <italic>HOX</italic> genes in normal hematopoiesis and acute leukemia</article-title>
          <source>Leukemia</source>
          <year>2013</year>
          <volume>27</volume>
          <fpage>1000</fpage>
          <lpage>1008</lpage>
          <pub-id pub-id-type="pmid">23212154</pub-id>
        </element-citation>
      </ref>
      <ref id="B16">
        <label>16</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Schneidman-Duhovny</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Inbar</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Nussinov</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Wolfson</surname>
              <given-names>HJ</given-names>
            </name>
          </person-group>
          <article-title>PatchDock and SymmDock: servers for rigid and symmetric docking</article-title>
          <source>Nucleic Acids Res</source>
          <year>2005</year>
          <volume>33</volume>
          <fpage>W363</fpage>
          <lpage>W367</lpage>
          <pub-id pub-id-type="pmid">15980490</pub-id>
        </element-citation>
      </ref>
    </ref-list>
    <sec sec-type="supplementary-material">
      <title>Supplementary materials</title>
      <p>Supplementary data including five tables can be found with this article online at <ext-link ext-link-type="uri" xlink:href="http://www.genominfo.org/src/sm/gni-13-45-s001.pdf">http://www.genominfo.org/src/sm/gni-13-45-s001.pdf</ext-link>.</p>
      <supplementary-material content-type="local-data" id="S1">
        <caption>
          <title>Supplementary Table 1</title>
          <p>miRNA target sites in <italic>HOXA9</italic> gene are highlighted using different color</p>
        </caption>
        <media mimetype="application" mime-subtype="pdf" xlink:href="gni-13-45-s001.pdf" orientation="portrait" id="d35e1216" position="anchor"/>
      </supplementary-material>
      <supplementary-material content-type="local-data" id="S2">
        <caption>
          <title>Supplementary Table 2</title>
          <p>Primary sequence of four miRNA (mir-145, mir-126, let-7a, and mir-196b)</p>
        </caption>
        <media mimetype="application" mime-subtype="pdf" xlink:href="gni-13-45-s002.pdf" orientation="portrait" id="d35e1223" position="anchor"/>
      </supplementary-material>
      <supplementary-material content-type="local-data" id="S3">
        <caption>
          <title>Supplementary Table 3</title>
          <p>miRNA-mRNA duplex sequences along with predicted binding sites in <italic>HOXA9</italic> gene are reported</p>
        </caption>
        <media mimetype="application" mime-subtype="pdf" xlink:href="gni-13-45-s003.pdf" orientation="portrait" id="d35e1233" position="anchor"/>
      </supplementary-material>
      <supplementary-material content-type="local-data" id="S4">
        <caption>
          <title>Supplementary Table 4</title>
          <p>Minimum free energy (MFE) score based miRNA-mRNA (HOXA9 gene) duplex and their predicted secondary structures are reported</p>
        </caption>
        <media mimetype="application" mime-subtype="pdf" xlink:href="gni-13-45-s004.pdf" orientation="portrait" id="d35e1240" position="anchor"/>
      </supplementary-material>
      <supplementary-material content-type="local-data" id="S5">
        <caption>
          <title>Supplementary Table 5</title>
          <p>Docking scores between miRNA and Argonaute protein resulted from PachDock online server</p>
        </caption>
        <media mimetype="application" mime-subtype="pdf" xlink:href="gni-13-45-s005.pdf" orientation="portrait" id="d35e1247" position="anchor"/>
      </supplementary-material>
    </sec>
  </back>
  <floats-group>
    <fig id="F1" orientation="portrait" position="float">
      <label>Fig. 1</label>
      <caption>
        <title>Three dimensional binding modes of mir-145, mir-126, let-7a, mir-196b.1, and mir-196b.2 with mRNA of <italic>HOXA9</italic> gene are deciphered in section (A), (B), (C), (D), and (E), respectively.</title>
      </caption>
      <graphic xlink:href="gni-13-45-g001"/>
    </fig>
    <fig id="F2" orientation="portrait" position="float">
      <label>Fig. 2</label>
      <caption>
        <title>Amino acid residues of Argonaute protein participating in the interaction with mir-145, mir-126, let-7a, mir-196b.1, and mir-196b.2 within distance of 3.5 &#xC5; are reported in section (A), (B), (C), (D), and (E), respectively.</title>
      </caption>
      <graphic xlink:href="gni-13-45-g002"/>
    </fig>
    <fig id="F3" orientation="portrait" position="float">
      <label>Fig. 3</label>
      <caption>
        <title>Amino acid residues of Argonaute protein participating in hydrogen bonding interaction with mir-145, mir-126, let-7a, mir-196b.1, and mir-196b.2 within distance of 3.0 &#xC5; are reported in section (A), (B), (C), (D), and (E), respectively.</title>
      </caption>
      <graphic xlink:href="gni-13-45-g003"/>
    </fig>
    <table-wrap id="T1" orientation="portrait" position="float">
      <label>Table 1</label>
      <caption>
        <title>Amino acid residues of Argonaute protein participating in the interaction with mir-145, mir-126, let-7a, mir-196b.1, and mir-196b.2 within a distance of 3.5 &#xC5;</title>
      </caption>
      <graphic xlink:href="gni-13-45-i001"/>
      <table-wrap-foot>
        <fn>
          <p><sup>a</sup>Amino acid residues involved in hydrophobic interactions; <sup>b</sup>Amino acid residues with aromatic rings; <sup>c</sup>Amino acid residues participating in hydrogen bonding.</p>
        </fn>
      </table-wrap-foot>
    </table-wrap>
    <table-wrap id="T2" orientation="portrait" position="float">
      <label>Table 2</label>
      <caption>
        <title>Amino acid residues of Argonaute protein participating in hydrogen bonding with miRNAs within a distance of 3.0 &#xC5;</title>
      </caption>
      <graphic xlink:href="gni-13-45-i002"/>
    </table-wrap>
  </floats-group>
</article>
</pmc-articleset>